Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 218 (1-2) , 39-45
- https://doi.org/10.1016/j.jns.2003.10.015
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Huntington's Disease Society of America
- Amyotrophic Lateral Sclerosis Association
- National Institutes of Health
- U.S. Department of Defense
- Hereditary Disease Foundation
This publication has 30 references indexed in Scilit:
- New insights into progressive supranuclear palsyTrends in Neurosciences, 2001
- Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosisNeuroReport, 2000
- Regulation of Matrix Metalloproteinase Expression in Astrocytes, Microglia and NeuronsNeuroimmunomodulation, 1996
- Matrix Metalloproteinases in the Neocortex and Spinal Cord of Amyotrophic Lateral Sclerosis PatientsJournal of Neurochemistry, 1996
- Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related DisordersJournal of Neuropathology and Experimental Neurology, 1996
- Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)Neurology, 1994
- The Family of Matrix MetalloproteinasesaAnnals of the New York Academy of Sciences, 1994
- A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursorNature, 1993
- Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the HippocampusJournal of Neurochemistry, 1992
- Progressive Supranuclear PalsyArchives of Neurology, 1964